BenQ Medical Technology (4116) — Free Cash Flow Generation Index
BenQ Medical Technology (4116) has a Free Cash Flow Generation Index of 0.92x as of June 2025. Free cash flow of NT$164.28 Million represents 1% of operating cash flow (NT$179.07 Million). Explore BenQ Medical Technology (4116) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BenQ Medical Technology Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for BenQ Medical Technology across 8 annual periods. For the full cash flow conversion analysis, see BenQ Medical Technology operating cash flow efficiency.
Annual Free Cash Flow Generation for BenQ Medical Technology (2017–2024)
Year-by-year Free Cash Flow Generation Index for BenQ Medical Technology. Check 4116 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | NT$46.74 Million | NT$222.22 Million | NT$175.48 Million | ▼ -69.3% |
| 2023 | 0.69x | NT$303.07 Million | NT$442.35 Million | NT$139.28 Million | ▼ -18.6% |
| 2022 | 0.84x | NT$318.72 Million | NT$378.77 Million | NT$60.05 Million | ▲ +15.5% |
| 2021 | 0.73x | NT$88.42 Million | NT$121.35 Million | NT$32.92 Million | ▲ +1.2% |
| 2020 | 0.72x | NT$109.12 Million | NT$151.48 Million | NT$42.37 Million | ▼ -17.7% |
| 2019 | 0.88x | NT$148.09 Million | NT$169.23 Million | NT$21.15 Million | ▲ +25.9% |
| 2018 | 0.70x | NT$87.67 Million | NT$126.10 Million | NT$31.36 Million | ▲ +223.0% |
| 2017 | -0.57x | NT$-41.26 Million | NT$72.97 Million | NT$112.31 Million | — |